Recurrent pericarditis in children: Clinical and therapeutic differences from adults A. Mauro, R. Mascolo, E. Bizzi, M. Sandini, V. Collini, R. Caorsi, F. La Torre, C. Celani, M. Cattalini, T. Giani, E. Del Giudice, D. Rigante, M.C. Maggio, L. Trotta, M. Pancrazi, E. Ceriani, S. Berra, F. Agozzino, S. Mannarino, M. Pasquinucci, A. Insalaco, R. Lubrano, G. Simonini, M. Gattorno, L. Bernardo, M. Imazio, A. Brucato International Journal of Cardiology, 2026
Risk of intestinal involvement in mucocutaneous-onset Behçet’s disease: data from the AIDA network registry Antonio Vitale, Valeria Caggiano, Jessica Sbalchiero, Francesco Gavioli, Giuseppe Lopalco, Gaafar Ragab, Silvana Guerriero, Ibrahim Almaglouth, Abdurrahman Tufan, Roberto Giacomelli, Haner Direskeneli, Piero Ruscitti, Gülen Hatemi, Francesco Carubbi, Ezgi Deniz Batu, Seza Ozen, Jurgen Sota, Henrique Ayres Mayrink Giardini, Micol Frassi, Petros P Sfikakis, Maria Morrone, Federica Gatti, Amina Maher, Ayman Abdel-Monem Ahmed Mahmoud, Rosanna Dammacco, Hamit Kucuk, Riza Can Kardas, Ibrahim Yahya Cakir, Letizia Pia di Corcia, Fatma Alibaz Öner, Gizem Sevik, Martina Gentile, Alican Karakoc, Alessia Alunno, Hulya Ercan Emreol, Francesca Crisafulli, Maria Tektonidou, Francesco Ciccia, Maissa Thabet, Serena Bugatti, Alessandra Milanesi, Maria Sole Chimenti, Benedetta Monosi, Matteo Piga, Alberto Floris, Andrea Hinojosa-Azaola, Guillermo Arturo Guaracha-Basañez, Cecilia Beatrice Chighizola, José Hernández-Rodríguez, Marco Cattalini, Marcello Govoni, Ombretta Viapiana, Adele Civino, Daniela Opris-Belinski, Carla Gaggiano, Rosaria Talarico, Annarita Giardina, Giacomo Emmi, Piercarlo Sarzi Puttini, Maria Cristina Maggio, Paola Parronchi, Piero Portincasa, Alejandra de-la-Torre, Juanita Cardona-López, Stefano Gentileschi, Angela Mauro, Gian Domenico Sebastiani, Maria Francesca Gicchino, Ali Şahin, Donato Rigante, Emre Bilgin, Emanuela Del Giudice, Luciana Breda, Amato De Paulis, Alberto Lo Gullo, Şükran Erten, Samar Tharwat, Lampros Fotis, Maier Armin, Antonella Insalaco, Anastasios Karamanakos, Alessandro Conforti, Özgül Soysal Gündüz, Abdelhfeez Moshrif, Francesca Li Gobbi, Stefania Costi, Elena Bartoloni, Patrizia Barone, Serena Guiducci, Andrés González-García, Inés Hernanz Rodriguez, Giovanni Conti, Annamaria Iagnocco, Fatos Önen, Sulaiman M. Al-Mayouf, Ali İbrahim Hatemi, Alberto Balistreri, Claudia Fabiani, Luca Cantarini Frontiers in Immunology, 2026 Objective Behçet’s disease (BD) may initially manifest solely with mucocutaneous involvement. This study aimed to identify demographic and clinical factors associated with subsequent intestinal involvement in patients presenting exclusively with mucocutaneous manifestations during early disease stages. Methods Data were obtained from the International AutoInflammatory Disease Alliance Network registry dedicated to BD; a Bayesian statistical approach was employed to address the limited sample size resulting from subgroup stratifications. Results In total, 328 BD patients with exclusively mucocutaneous onset were enrolled; of these, 46 (14%) developed intestinal involvement over time. The risk of ocular involvement was higher among patients with intestinal manifestations (OR: 3.02, 95% CrI: 1.24–6.08; posterior probability: 99.3%). Minor aphthous ulcers without major aphthosis were protective towards intestinal involvement (OR: 0.47, 95% CrI: 0.22–0.98; posterior probability: 97.98%). Conversely, major aphthous ulcers increased the risk (OR: 3.25, 95% CrI: 1.50–7.02; posterior probability: 99.7%), along with the combination of oral major aphthosis with: i) genital aphthosis (OR = 2.77, 95%CrI: 1.14-6.58; posterior probability: 98.45%); ii) pseudofolliculitis (OR = 3.18, 95%CrI: 1.15-8.33; posterior probability: 98.72%); iii) genital aphthosis plus pseudofolliculitis (OR = 5.22, 95%CrI: 1.71-16.35; posterior probability of 99.77%). Pseudofolliculitis plus cutaneous manifestations other than erythema nodosum were protective against intestinal involvement (OR = 0.01, 95%CrI: 0.0-0.98; posterior probability: 97.55%). Conclusion Major aphthosis was the strongest factor associated with intestinal involvement in BD patients initially presenting with mucocutaneous symptoms only. In such patients, intestinal involvement correlated with increased risk of ocular inflammation.
A multicenter real-world, open-label study assessing the impact of a probiotic mixture on symptoms of irritable bowel syndrome in adults Lorenzo Drago, Vito D. Corleto, Giorgio Ciprandi, Viviana Fara Brindicci, Vanessa Nadia Dargenio, et al. Beneficial Microbes, 2026 Irritable bowel syndrome (IBS) is faced by gastroenterologists daily, and probiotics are a potential therapeutic tool; however, there are no strain recommendations. This multicenter, real-world, single-arm, open-label study aims to assess a novel probiotic mixture's effectiveness, safety, and patient satisfaction in patients with IBS. This study was conducted by 52 Italian gastroenterologists across 16 of the 21 Italian regions who enrolled patients with IBS (n = 1,098). Throughout the 8-week treatment (T1) period with a probiotic mixture (Lactobacillus paracasei 101/37 LMG P-17504, Lactobacillus plantarum 14D CECT 4528, Bifidobacterium breve Bbr8 LMG P-17501, Bifidobacterium breve BL10 LMG P-17500, and Bifidobacterium animalis ssp. lactis Bi1 LMG P-17502), participants completed a questionnaire to evaluate IBS symptoms at baseline, at the end of treatment, and after one-month follow-up (T2). The primary outcome was the progress of abdominal pain and bloating according with a 5-point Likert scale, (0 absence and 5 highly intense symptoms) and treatment success was defined as a change towards categories of lower IBS severity for abdominal pain and/or bloating. Treatment success for abdominal pain and bloating was achieved in 73% and 81.9% at T1 and 68% and 73.1% at T2, respectively. The probiotic was associated with significantly reducing abdominal pain and bloating at T1 and T2 (P < 0.001). Patients with regular bowel movements increased to 68.5% at T1 and 68.7% at T2, respectively (P < 0.001). Patients reporting that IBS did not affect their daily life increased from 1.8% at entry to 22.7% at T1 and 41.6% at T2 (P < 0.001). This real-world, single-arm, open-label study showed that an 8-week treatment with a novel probiotic mixture is effective, safe, well tolerated, and can improve patients' social lives during and after treatment. Future randomised placebo-controlled studies are necessary to validate these findings. The trial is registered at www.ClinicalTrials.gov (NCT06610149).
Application of machine learning techniques to explore the occurrence of macrophage activation syndrome in Still’s disease: results from the GIRRCS AOSD Study Group and the AIDA Network Still’s Disease Registry Piero Ruscitti, Francesco Masedu, Antonio Vitale, Valeria Caggiano, Ilenia Di Cola, Fabiola Atzeni, Jessica Sbalchiero, Giuseppe Lopalco, Florenzo Iannone, Maria Morrone, Daniela Iacono, Flavia Riccio, Mariachiara Visconti, Carla Gaggiano, Francesco Caso, Giacomo Emmi, Andrea Hinojosa-Azaola, Jiram Torres-Ruiz, Eduardo Martín-Nares, Giuliana Guggino, Lidia La Barbera, Ezgi D. Batu, Seza Ozen, Petros P. Sfikakis, Luca Navarini, Luisa Costa, Abdurrahman Tufan, Ibrahim Yahya Cakir, Federico Perosa, José Hernández-Rodríguez, Marcella Prete, Lorenzo Dagna, Corrado Campochiaro, Francesco Ursini, Paolo Sfriso, Sara Bindoli, Henrique A. Mayrink Giardini, Lampros Fotis, Katerina Kourtesi, Gaafar Ragab, Mahmoud Ghanema, Moustafa Ali Saad, Haner Direskeneli, Anastasios Karamanakos, Alessandro Conforti, Francesco La Torre, Micol Frassi, Marcello Govoni, Paola Parronchi, Piercarlo Sarzi-Puttini, Maria Cristina Maggio, Serena Bugatti, Ludovico De Stefano, Jacopo Pelizza, Elena Bartoloni, Donato Rigante, Annamaria Iagnocco, Ombretta Viapiana, Ewa Wiesik-Szewczyk, Joanna Makowska, Özgül Soysal Gündüz, Şükran Erten, Benson Ogunjimi, Gian Domenico Sebastiani, Emanuela Del Giudice, Edoardo Biancalana, Giovanni Conti, Ibrahim A. AlMaghlouth, Luciana Breda, Antonio Gidaro, Patrizia Barone, Alma Nunzia Olivieri, Francesco Carubbi, Amato De Paulis, Maria Sole Chimenti, Alberto Lo Gullo, Samar Tharwat, Maissa Thabet, Abdelhfeez Moshrif, Maria Alessio, Angela Mauro, Benoit Suzon, Valentina Pucino, Oksana Boyarchuk, Tetiana Kovalchuk, Cemal Bes, Rabia Deniz, Sulaiman M. Al-Mayouf, Paola Cipriani, Marco Valenti, Alberto Balistreri, Claudia Fabiani, Francesco Ciccia, Carlomaurizio Montecucco, Roberto Giacomelli, Bruno Frediani, Luca Cantarini Frontiers in Immunology, 2026 Objectives This study aims to explore the application of machine learning techniques in assessing macrophage activation syndrome (MAS) in Still’s disease. Methods A multicenter, observational, prospective study was conducted, including patients with Still’s disease enrolled in the Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) AOSD Study Group and the AutoInflammatory Disease Alliance (AIDA) Network Still’s Disease Registry. Results A total of 737 patients (age: 35.5 ± 17.8, male sex: 44.7%) with Still’s disease were assessed; 11.4% were affected by MAS, and 3% had a poor prognosis. First, random forest imputation was applied to the original dataset. Subsequently, a machine-learning-driven assessment was developed to explore MAS occurrence. Collectively, regression models, an exploration decision tree, and a random forest were applied, suggesting the importance of ferritin, age, C-reactive protein (CRP), and systemic score. A logistic regression model accounting for data leakage concerns was then generated using these variables, and missing values were imputed using random forest imputation. This analysis supported the role of the selected variables, which were further combined across different clinical scenarios to estimate the probability of MAS. The highest risk of MAS was estimated for patients simultaneously characterized by age ≥ 45 years, ferritin ≥ 4,178.10 ng/mL, CRP ≥ 27.15 mg/L, and a systemic score ≥ 7, corresponding to a 34.7% probability of MAS, as well as for those characterized by ferritin ≥ 4,178.10 ng/mL, CRP ≥ 27.15 mg/L, and systemic score ≥ 7, corresponding to a 33.5% probability of MAS. Conclusions A machine-learning-driven prediction of MAS was explored in Still’s disease, highlighting the importance of age of onset, hyperferritinaemia, increased CRP, and multiorgan involvement. A combination of these features may suggest a clinician-friendly algorithm for stratifying the probability of MAS during Still’s disease.
Depemokimab and the twice-yearly regimen: pharmacological implications and therapeutic positioning in severe eosinophilic respiratory diseases A. M. Marra, E. Bizzi, A. Gidaro, F. Bini, S. Rotunno, S. Modica, E. Greco, A. Mauro, R. Mascolo, E. Tombetti, M. Lazzeroni, F. Paciullo, G. Abatianni, C. Gagliardi, S. Damanti, P. Rovere Querini Frontiers in Immunology, 2026 Type 2 inflammatory diseases (T2D), notably severe eosinophilic asthma (SEA) and chronic rhinosinusitis with nasal polyps (CRSwNP), represent a significant global health burden due to their high morbidity, frequent exacerbations and reliance on systemic glucocorticoids (SGCs). Targeting Interleukin-5 (IL-5), a key driver of eosinophil production and survival, has emerged as a validated therapeutic strategy. Depemokimab is a novel, first-in-class anti-IL-5 monoclonal antibody (mAb) engineered with an extended half-life via the YTE amino acid modification of its Fc region, enabling an unprecedented twice-yearly dosing interval. This review synthesizes clinical data from the Phase III SWIFT (SEA) and ANCHOR (CRSwNP) programs, demonstrating depemokimab’s sustained eosinophil depletion and significant reduction in asthma exacerbation rates (annualized asthma exacerbation rate reduction of approximately 54% versus placebo). While efficacy on secondary endpoints such as lung function (FEV1) and quality of life (QoL) was mixed, the efficacy in reducing nasal polyp size (Nasal Polyp Score and Nasal Congestion) in CRSwNP was clear. The core value proposition of depemokimab is the combination of established IL-5 inhibition efficacy with patient convenience due to its dosing. We discuss its pharmacodynamic profile, safety and pivotal role in shifting the treatment paradigm towards simplified chronic disease management, positioning depemokimab as a novel, patient-centric option in the competitive landscape of T2 biologic therapies.
Reproductive Life Stages and Female Sex-Specific Patterns in Uveitis Activity: Data From the AIDA Network Uveitis Registry CARLA GAGGIANO, ALEJANDRA DE-LA-TORRE, SILVANA GUERRIERO, RAFAEL TIERRADENTRO-ALAPE, GAAFAR RAGAB, ANGIE FORERO-URIBE, STEFANIA COSTI, ROSANNA DAMMACCO, MARIA PIA PAROLI, MOHAMED THARWAT HEGAZY, EMANUELA DEL GIUDICE, JURGEN SOTA, ANDREA HINOJOSA-AZAOLA, LUCIANA BREDA, ANTONIO VITALE, ALEX FONOLLOSA, ADELE CIVINO, STEFANO GENTILESCHI, MARCO CATTALINI, ANGELA MAURO, VALERIA CAGGIANO, SOAD HASHAD, JESSICA SBALCHIERO, PIERO RUSCITTI, MARIA SOLE CHIMENTI, MARIA TARSIA, HENRIQUE AYRES MAYRINK GIARDINI, ALESSANDRO CONFORTI, SAMAR THARWAT, FRANCESCO CARUBBI, ABDELHAFEEZ MOSHRIF, JOSÉ HERNÁNDEZ-RODRÍGUEZ, LAMPROS FOTIS, SERENA BUGATTI, SULAIMAN AL-MAYOUF, ANASTASIOS KARAMANAKOS, MATTEO PIGA, FRANCESCA MINOIA, MARIA CRISTINA MAGGIO, GIAN DOMENICO SEBASTIANI, GIOVANNI CONTI, PATRIZIA BARONE, PERLA AYUMI KAWAKAMI-CAMPOS, GIUSEPPE LOPALCO, FRANCESCO LA TORRE, MARIA FRANCESCA GICCHINO, SEZA OZEN, EZGI DENIZ BATU, BRUNO FREDIANI, LUCA CANTARINI, CLAUDIA FABIANI American Journal of Ophthalmology, 2026 OBJECTIVE OR PURPOSE: To investigate whether noninfectious uveitis (NIU) activity varies across reproductive life stages (RLS) according to sex. DESIGN: Observational, retrospective, cross-sectional registry-based study. SUBJECTS, PARTICIPANTS, AND/OR CONTROLS: The study recruited female patients with NIU (regardless of anatomical location or underlying etiology) as the main study group and male patients as controls to allow sex-based comparisons. They were enrolled in the AIDA Network Uveitis Registry between 2020 and 2025. METHODS, INTERVENTION, OR TESTING: RLS (prepuberal, early puberty, late puberty, reproductive, perimenopause, and podtmenopausal) were approximated using age intervals derived from epidemiological data. Study outcomes were flare frequency, anterior chamber cells (ACC), anterior chamber flare, vitreous haze, new posterior segment inflammatory signs, and immunosuppressive treatment (IST) exposure. RESULTS: Four hundred twenty-five female and 275 male patients were included. Median (IQR) relapse number in 12 months was 0.8 (1.3) [min 0.0-max 2.0] in prepuberty, 1.0 (2.0) [0.0-5.0] in early puberty, 0.0 (1.0) [0.0-5.0] in late puberty, 0.5 (1.0) [0.0-8.0] in reproductive age, 1.0 (1.0) [0.0-10.0] in perimenopause, and 0.5 (1.0) [0.0-7.5] in post-menopause (P = .014). There was a statistically significant interaction between RLS and sex (P = .044), with a perimenopausal peak retained only in women. In subjects with active anterior involvement, differences in the distribution of ACC grades among RLS were observed, with a peak in prepuberty and early puberty (P = .004). Proportions of subjects receiving IST were higher in prepuberty and puberty than in the remaining RLS (P = .012). CONCLUSIONS: RLS are clinically relevant modifiers of uveitis activity and should guide patient education, risk stratification, and therapy. Early puberty and perimenopause increase relapse risk; pediatric cases show more severe anterior inflammation and require more systemic IST.
Risk of major organ involvement in Behçet's patients with mucocutaneous onset: Data from the AIDA Network Registry Antonio Vitale, Francesco Gavioli, Valeria Caggiano, Jessica Sbalchiero, Giuseppe Lopalco, Gaafar Ragab, Silvana Guerriero, Ibrahim AlMaglouth, Abdurrahman Tufan, Roberto Giacomelli, Haner Direskeneli, Piero Ruscitti, Gülen Hatemi, Francesco Carubbi, Ezgi Deniz Batu, Seza Ozen, Jurgen Sota, Henrique Ayres Mayrink Giardini, Micol Frassi, Petros P Sfikakis, Florenzo Iannone, Maria Morrone, Mahmoud Ghanema, Moustafa Ali Saad, Rosanna Dammacco, Hamit Kucuk, Riza Can Kardas, Ibrahim Yahya Cakir, Luca Navarini, Fatma Alibaz Öner, Gizem Sevik, Martina Gentile, Alican Karakoc, Alessia Alunno, Hulya Ercan Emreol, Francesca Crisafulli, George Fragoulis, Francesco Ciccia, Maissa Thabet, Serena Bugatti, Alessandra Milanesi, Maria Sole Chimenti, Benedetta Monosi, Matteo Piga, Alberto Floris, Andrea Hinojosa-Azaola, Guillermo Arturo Guaracha-Basañez, Cecilia Beatrice Chighizola, José Hernández-Rodríguez, Marco Cattalini, Marcello Govoni, Ombretta Viapiana, Adele Civino, Daniela Opris-Belinski, Carla Gaggiano, Rosaria Talarico, Annarita Giardina, Giacomo Emmi, Piercarlo Sarzi Puttini, Maria Cristina Maggio, Paola Parronchi, Piero Portincasa, Alejandra de-la-Torre, Blanca Aguilar-Barrera, Stefano Gentileschi, Angela Mauro, Gian Domenico Sebastiani, Alma Nunzia Olivieri, Ali Şahin, Donato Rigante, Emre Bilgin, Emanuela Del Giudice, Luciana Breda, Amato De Paulis, Alberto Lo Gullo, Şükran Erten, Samar Tharwat, Lampros Fotis, Armin Maier, Antonella Insalaco, Anastasios Karamanakos, Alessandro Conforti, Özgül Soysal Gündüz, Abdelhfeez Moshrif, Francesca Li Gobbi, Alberto Balistreri, Elena Bartoloni, Patrizia Barone, Serena Guiducci, Andrés Gonzáles-García, Inés Hernanz Rodriguez, Giovanni Conti, Annamaria Iagnocco, Fatos Önen, Sulaiman M Al-Mayouf, Didar Ucar, Bruno Frediani, Claudia Fabiani, Luca Cantarini, and Rheumatology, 2026 Objectives The progression of Behçet’s disease (BD) from a mucocutaneous-limited form to major organ involvement (MOI) represents a significant challenge. This study aims to identify patients without MOI at BD onset who are at increased risk of developing MOI in later stages. Methods Patients’ data were drawn from the International AutoInflammatory Disease Alliance (AIDA) Network registry dedicated to BD. Results A total of 328 patients with exclusively mucocutaneous manifestations at BD onset were enrolled. Of these, 82 patients (25%) developed MOI over the entire follow-up period. Patients with minor oral aphthosis and no major oral aphthosis exhibited a reduced risk of developing MOI, with an odds ratio (OR) of 0.41 [95% confidence interval (95%CI): 0.22–0.79, P = 0.008]. Conversely, patients with both major and minor oral aphthosis had a significantly higher risk of developing MOI, with an OR of 12.76 (95%CI: 1.44–113, P = 0.02). Moreover, the development of MOI was associated with major oral aphthosis plus genital aphthosis (OR: 2.49, 95%CI: 1.1–5.6, P = 0.03), major oral aphthosis plus pseudofolliculitis (OR: 2.9, 95%CI: 1.15–7.4, P = 0.02) and major oral aphthosis plus both genital aphthosis and pseudofolliculitis (OR: 3.73, 95%CI: 1.22–11.4, P = 0.02). A positive family history for BD was associated with MOI (OR: 2.85, 95%CI: 1.08–7.58, P = 0.03). Conclusion A positive family history and the presence of major oral aphthosis combined with minor oral aphthosis, genital aphthosis or pseudofolliculitis are associated with MOI development in patients with mucocutaneous BD at onset.
Hydroxychloroquine for recurrent pericarditis: A multicentre observational study Lucia Trotta, Francesco Agozzino, Silvia Berra, Ruggiero Mascolo, Francesco Rubuano, Olga Blagova, George Lazaros, Elisa Ceriani, Massimo Pancrazi, Angela Mauro, Emilia Lazarou, Nicola Marotta, Francesca Casarin, Ludovico L. Sicignano, Massimo Imazio, Antonio Brucato European Journal of Internal Medicine, 2026 AIM: To assess the effect of hydroxychloroquine (HCQ) in recurrent pericarditis (RP). METHODS: International longitudinal observational study including 80 patients with idiopathic or post-cardiac injury RP, treated with HCQ for at least 6 months (April 2014-August 2025); 3 other patients stopped HCQ within 6 months for side-effects. Recurrences, hospitalizations, side effects and therapies were evaluated before and after HCQ. Patient and physician-reported effectiveness were recorded. RESULTS: Females were 57/80 (71 %); median age 51.5 years [IQR 43.8-62.8]. C-reactive protein (CRP) was >10mg/L in 52 (65 %) patients. The median follow-up after starting HCQ was 27.3 [11.7-47.8] months, and the daily dose was 400 mg in 52 patients (65 %) and 200 mg in 28 (35 %). Among the 62 patients treated with HCQ for at least 12 months, recurrences decreased in the 12 months following treatment (median 1 [0-2]) compared with the 12 months preceding it (median 2 [1-3])(p < 0.001), as well as hospitalizations (5 vs 32) (p < 0.001). HCQ was effective either in CRP positive or CRP negative subjects. Fifty-four patients (67.5 %) were on steroids when HCQ was started, but only 21 (26.3 %) continued them at the last follow-up (p < 0.001); the median daily dose of prednisone was reduced from 10.0 mg [7.5-17.5] to 5.0 [2.5-5.0] (p < 0.001). Regarding patients' opinions about HCQ effectiveness, 64 pts (80 %) judged it useful, 16 (20 %) neutral (8 stopped HCQ for lack of effectiveness); the physicians' opinions were similar (concordance rate 74 (93.7 %), k 0.777; p < 0.001). CONCLUSIONS: HCQ reduced recurrences, hospitalizations, and corticosteroid dose in RP, with no relevant side effects.
The Risk of Developing Ocular Involvement Among Behçet’s Disease Patients Presenting with Mucocutaneous Involvement at Disease Onset: Data from the International AIDA Network Behçet’s Disease Registry Antonio Vitale, Valeria Caggiano, Jessica Sbalchiero, Giuseppe Lopalco, Gaafar Ragab, Silvana Guerriero, Ibrahim AlMaglouth, Abdurrahman Tufan, Roberto Giacomelli, Haner Direskeneli, Piero Ruscitti, Gülen Hatemi, Francesco Carubbi, Ezgi Deniz Batu, Seza Ozen, Jurgen Sota, Henrique Ayres Mayrink Giardini, Micol Frassi, Petros P. Sfikakis, Federica Gatti, Claudia Ammoscato, Amina Maher, Ayman Abdel-Monem Ahmed Mahmoud, Rosanna Dammacco, Hamit Kucuk, Riza Can Kardas, Ibrahim Yahya Cakir, Fatma Alibaz Öner, Gizem Sevik, Martina Gentile, Alican Karakoc, Alessia Alunno, Hulya Ercan Emreol, Francesca Crisafulli, Katerina Laskari, Francesco Ciccia, Maissa Thabet, Naceur Feriel, Serena Bugatti, Alessandra Milanesi, Maria Sole Chimenti, Benedetta Monosi, Matteo Piga, Alberto Floris, Francesco Gavioli, Cecilia Beatrice Chighizola, José Hernández-Rodríguez, Marco Cattalini, Marcello Govoni, Ombretta Viapiana, Adele Civino, Daniela Opris-Belinski, Carla Gaggiano, Rosaria Talarico, Annachiara Alemanno, Annarita Giardina, Giacomo Emmi, Piercarlo Sarzi Puttini, Maria Cristina Maggio, Paola Parronchi, Piero Portincasa, Alejandra de-la-Torre, Laura Daniela Rodríguez-Camelo, Stefano Gentileschi, Angela Mauro, Gian Domenico Sebastiani, Alma Nunzia Olivieri, Ali Şahin, Donato Rigante, Emre Bilgin, Emanuela Del Giudice, Luciana Breda, Amato De Paulis, Alberto Lo Gullo, Şükran Erten, Samar Tharwat, Lampros Fotis, Armin Maier, Antonella Insalaco, Anastasios Karamanakos, Alessandro Conforti, Özgül Soysal Gündüz, Abdelhfeez Moshrif, Francesca Li Gobbi, Stefania Costi, Elena Bartoloni, Patrizia Barone, Serena Guiducci, Andrés Gonzáles-García, Inés Hernanz Rodriguez, Giovanni Conti, Annamaria Iagnocco, Fatos Önen, Sulaiman M. Al-Mayouf, Didar Uçar, Alberto Balistreri, Bruno Frediani, Luca Cantarini, Claudia Fabiani Ophthalmology and Therapy, 2026 INTRODUCTION: Behçet's disease (BD) frequently arises with exclusively mucocutaneous involvement, but some patients will develop major organ involvement, including ocular inflammation. This study aims to assess the patients' demographic and clinical characteristics that may be associated with the development of ocular involvement in patients with BD with exclusively mucocutaneous involvement in the early stages. METHODS: Patients' data were collected in the International AutoInflammatory Disease Alliance (AIDA) Network registry dedicated to BD. RESULTS: A total of 328 patients with BD were enrolled, 36 (11%) of whom developed ocular involvement over time. The following variables were significantly associated with the development of ocular inflammation at binary logistic regression: positive family history for BD (OR 4.32, 95% CI 1.16-14.72, p = 0.02), Arab ethnicity (OR 3.6, 95% CI 1.3-9.9, p = 0.01), presence of major oral aphthous ulceration (OR 3.26, 95% CI 1.18-8.99, p = 0.02), pseudofolliculitis plus erythema nodosum (OR 4.58, 95% CI 1.33-15.7, p = 0.016); conversely, white patients/patients of European descent (OR 0.33, 95% CI 0.12-0.91, p = 0.03) and the presence of a low number (one to two) ulcers at genital aphthous flares (OR 0.002, 95% CI ~ 0-0.07, p = 0.0006) were protective against the occurrence of ocular inflammatory manifestations. Genital aphthosis with more than five concurrent ulcers was associated with eye involvement in Arab patients (OR 209.2, 95% CI 5.8-7497, p = 0.003). CONCLUSIONS: Major oral aphthosis, genital aphthous attacks with more than five concurrent ulcers, erythema nodosum coexisting with pseudofolliculitis, a positive family history of BD, and Arab ethnicity are associated with a higher risk of ocular involvement when BD arises with the sole mucocutaneous involvement.
Musculoskeletal manifestations in children with inflammatory bowel disease: a multicenter cohort study (GASTROREUM study) Adele Civino, Federico Diomeda, Romina Gallizzi, Marco Gattorno, Silvia Magni-Manzoni, Davide Montin, Gabriele Simonini, Giovanni Conti, Emanuela Del Giudice, Giovanni Filocamo, Fortunata Civitelli, Angela Miniaci, Serena Pastore, Francesco La Torre, Bianca Lattanzi, Angela Mauro, Lorenzo Mambelli, Patrizia Barone, Alma Nunzia Olivieri, Gianluca Vergine, Maria Cristina Maggio, Ilenia Floretta, Simona Campus, Luca Cantarini, Emanuela Sacco, Michela Cappella, Serena Arrigo, Giusyda Tarantino, Manuela Taurisano, Silvia Greco, Rossella Greco, Fabrizio De Benedetti, Francesca Bovis, Angelo Ravelli, , Pierandrea Elefante, Alessandra Spagnolo, Francesco Chiarelli, Edoardo Marrani, Chiara Longo, Riccardo Lubrano, Giulia Loiacono, Cecilia Lugarà, Federica D’Amico, Arianna Petrillo, Rosaria Celano, Maria Francesca Gicchino, Francesca Cavataio, Alessandro De Fanti, Valeria Dell’Omo, Elisabetta Cortis, Federica Ferrari, Francesca Ardenti Morini, Francesca Soscia, Maria Pastore, Ilaria Battagliere, Eleonora Prete, Andrea Taddio Pediatric Rheumatology, 2025
Incidence and Predictors of Ocular Complications in Pediatric-Onset Uveitis: Data from the AIDA Network Uveitis Registry Carla Gaggiano, Alejandra De-la-Torre, Juanita Cardona-López, Silvana Guerriero, Gaafar Ragab, Maria Pia Paroli, Luciana Breda, Emanuela Del Giudice, Maria Tarsia, Jurgen Sota, Adele Civino, Marco Cattalini, Antonio Vitale, Stefano Gentileschi, Angela Mauro, Sulaiman Al-Mayouf, Soad Hashad, Alex Fonollosa, Shereen Hassan Aboul Naga, Rana Hussein Amin, Lampros Fotis, Maria Francesca Gicchino, Valeria Caggiano, Rosanna Dammacco, Maria Cristina Maggio, Daniela Rodríguez-Camelo, Maria Sole Chimenti, Juliana Lopez-Bonilla, Ezgi Deniz Batu, Seza Ozen, Francesca Minoia, Abdurrahman Tufan, Mohamed Tharwat Hegazy, Kalpana Babu, Jessica Sbalchiero, Abdelhafeez Moshrif, Patrizia Barone, Perla Ayumi Kawakami-Campos, Alessandro Conforti, Marcello Govoni, Giovanni Conti, Maissa Thabet, Francesco La Torre, Ester Carreño, Vishali Gupta, Bruno Frediani, Luca Cantarini, Claudia Fabiani, and Ophthalmology and Therapy, 2025
Adalimumab Monotherapy or Combination Therapy With Methotrexate in Paediatric Uveitis: Data From the AIDA Network Uveitis Registry Carla Gaggiano, Alejandra de‐la‐Torre, Silvana Guerriero, Stefania Costi, Gaafar Ragab, Maria Pia Paroli, Emanuela Del Giudice, Luciana Breda, Saverio La Bella, Marco Cattalini, Maria Cristina Maggio, Alex Fonollosa, Ester Carreño, Maria Tarsia, Rosanna Dammacco, Soad Hashad, Antonio Vitale, Lampros Fotis, Stefano Gentileschi, Francesca Minoia, Germán Mejía‐Salgado, Halah Etayari, Paola Saboya‐Galindo, María Andrea Bernal‐Valencia, Adele Civino, Maria Sole Chimenti, Valeria Caggiano, Maria Francesca Gicchino, Jurgen Sota, Angela Mauro, Giuseppe Lopalco, Kalpana Babu Murthy, Mohamed Tharwat Hegazy, Vishali Gupta, Francesco La Torre, Rana Hussein Amin, Bruno Frediani, Gian Marco Tosi, Luca Cantarini, Claudia Fabiani, and Clinical and Experimental Ophthalmology, 2025
Influence of gender on Behçet's disease phenotype and irreversible organ damage: Data from the International AIDA Network Behçet's Disease Registry Jurgen Sota, Gaafar Ragab, Ibrahim AlMaglouth, Giuseppe Lopalco, Abdurrahman Tufan, Haner Direskeneli, Andrea Hinojosa-Azaola, Henrique Ayres Mayrink Giardini, Silvana Guerriero, Paola Triggianese, Petros P. Sfikakis, Matteo Piga, Piero Ruscitti, Marcello Govoni, Annamaria Iagnocco, Francesco Carubbi, José Hernández-Rodríguez, Ahmed Hatem Laymouna, Ayman Abdel-Monem Ahmed Mahmoud, Mahmoud Ghanema, Aos A. Aboabat, Kazi Nur Asfina, Fehaid Alanazi, Maria Morrone, Veronica Spedicato, Hamit Kucuk, Riza Kardas, Fatma Alibaz Öner, Gizem Sevik, Jiram Torres-Ruiz, Perla Ayumi Kawakami-Campos, Isabelle Parente de Brito Antonelli, Rosanna Dammacco, Maria Sole Chimenti, Katerina Arida, Alberto Floris, Martina Gentile, Francesca Ruffilli, Elisa Bellis, Alessia Alunno, Gerard Espinosa, Stefano Gentileschi, Carla Gaggiano, Antonio Vitale, Valeria Caggiano, Roberta Lopez, Maria Tarsia, Sara Monti, Gülen Hatemi, Alican Karakoç, Micol Frassi, Roberto Giacomelli, Samar Tharwat, Maissa Thabet, Francesco Ciccia, Giacomo Emmi, Ombretta Viapiana, Ali Şahin, Gian Domenico Sebastiani, Ezgi Deniz Batu, Seza Ozen, Seher Sener, Daniela Opris-Belinski, Stefania Costi, Alessandro Conforti, Marco Cattalini, Elena Bartoloni, Nurullah Akkoç, Ozgul Soysal Gunduz, Giovanni Conti, Armin Maier, Annarita Giardina, Francesca Li Gobbi, Paola Parronchi, Piercarlo Sarzi Puttini, Luciana Breda, Amato De Paulis, Ester Carreño, Francesco La Torre, Ewa Więsik-Scewczyk, Alejandra de-la Torre, Germán Mejía-Salgado, Farhad Shahram, Serena Guiducci, Maria Cristina Maggio, Emma Aragona, Donato Rigante, Alessandro Ciavarro, Fatos Önen, Şükran Erten, Antonella Insalaco, Emanuela Del Giudice, Patrizia Barone, Francesca Gicchino, Antonio Brucato, Alberto Lo Gullo, Angela Mauro, Anastasios Karamanakos, Alberto Balistreri, Maria Antonietta Mazzei, Bruno Frediani, Claudia Fabiani, Luca Cantarini Joint Bone Spine, 2025
Predictors of uveitic macular edema and functional prognostic outcomes: real-life data from the international AIDA Network uveitis registry Jurgen Sota, Germán Mejía-Salgado, Silvana Guerriero, Gaafar Ragab, Stefania Costi, Maria Pia Paroli, Andrea Hinojosa-Azaola, Giuseppe Lopalco, Luciana Breda, Henrique Ayres Mayrink Giardini, Alex Fonollosa, Maria Sole Chimenti, Antonio Vitale, Carla Gaggiano, Blanca Aguilar-Barrera, Laura Daniela Rodríguez-Camelo, Guillermo Arturo Guaracha-Basañez, Mohamed Tharwat Hegazy, Rosanna Dammacco, Valeria Albano, Eduardo Martín-Nares, Santiago Espinosa-Lugo, Mahmoud Ghanema, Maria Morrone, Saverio La Bella, Rafael Alves Cordeiro, Francesco Carubbi, Alessandro Conforti, Piero Ruscitti, Ibrahim AlMaglouth, Rosaria Talarico, Stefano Gentileschi, Petros P. Sfikakis, Valeria Caggiano, Matteo Piga, Adele Civino, Francesca Ricci, Maissa Thabet, Marcello Govoni, Abdurrahman Tufan, Francesca Crisafulli, Jessica Sbalchiero, Sulaiman M. Al-Mayouf, Angela Mauro, Soad Hashad, Francesca Minoia, Alma Nunzia Olivieri, Samar Tharwat, Maria Cristina Maggio, Abdelhfeez Moshrif, Gian Domenico Sebastiani, Daniela Opris-Belinski, Gülen Hatemi, Haner Direskeneli, Fatma Alibaz-Öner, Lampros Fotis, José Hernández-Rodríguez, Giovanni Conti, Piercarlo Sarzi Puttini, Ombretta Viapiana, Annarita Giardina, Patrizia Barone, Kalpana Babu, Rana Hussein Amin, Perla Ayumi Kawakami-Campos, Vishali Gupta, Annamaria Iagnocco, Ali Şahin, Antonella Insalaco, Andrés González-García, Ezgi Deniz Batu, Ester Carreño, Emanuela Del Giudice, Cecilia Beatrice Chighizola, Fabrizio Conti, Alberto Balistreri, Bruno Frediani, Luca Cantarini, Alejandra de-la-Torre, Claudia Fabiani Frontiers in Medicine, 2025
Impact of HLA-B51 on Uveitis and Retinal Vasculitis: Data from the AIDA International Network Registries on Ocular Inflammatory Disorders Jurgen Sota, Silvana Guerriero, Giuseppe Lopalco, Abdurrahman Tufan, Gaafar Ragab, Ibrahim AlMaglouth, Marcello Govoni, Petros P. Sfikakis, Micol Frassi, Antonio Vitale, Riza Can Kardas, Paola Triaggianese, Maria Sole Chimenti, Aos A. Aboabat, Matteo Piga, Sara Monti, Gian Domenico Sebastiani, Derya Yildirim, Alessandro Conforti, Stefano Gentileschi, Rosanna Dammacco, Andrea Hinojosa-Azaola, Perla Ayumi Kawakami-Campos, Francesca Ruffilli, Jiram Torres-Ruiz, Maissa Thabet, Amira Atig, Piero Ruscitti, Giulia Cataldi, Ombretta Viapiana, Gülen Hatemi, Alican Karakoç, Stefania Costi, Annamaria Iagnocco, Francesca Crisafulli, George Fragoulis, Emanuela Del Giudice, Mohamed Tharwat Hegazy, Maria Pia Paroli, Ali Şahin, Maria Morrone, Florenzo Iannone, Daniela Opris-Belinski, Kazi Nur Asfina, Patrizia Barone, Carla Gaggiano, Hamit Kucuk, Maria Francesca Gicchino, Francesco Carubbi, Valeria Caggiano, Katerina Laskari, Samar Tharwat, Haner Direskeneli, Fatma Alibaz-Oner, Gizem Sevik, Armin Maier, Ahmed Hatem Laymouna, Giacomo Emmi, Nurullah Akkoç, Maria Tarsia, Jessica Sbalchiero, Giovanni Conti, Rosaria Spinella, Francesco La Torre, Enrico Tombetti, Rana Hussein Amin, Angela Mauro, Anastasios Karamanakos, Ester Carreño, Alex Fonollosa, Marco Cattalini, Luciana Breda, Alejandra de-la-Torre, Ewa Wiesik-Szewczyk, Carlos Cifuentes-González, Seza Ozen, Maria Antonietta Mazzei, Gian Marco Tosi, Bruno Frediani, Alberto Balistreri, Ezgi Deniz Batu, Vishali Gupta, Luca Cantarini, Claudia Fabiani Ocular Immunology and Inflammation, 2025
D-Dimer and procalcitonin in patients with recurrent pericarditis: a prospective study Angela Mauro, Emanuele Bizzi, Maddalena Alessandra Wu, Ruggiero Mascolo, Camilla Chirico, Edoardo Conte, Enrica Negro, Lisa Serati, Alice Pedroli, Chiara Carollo, Martina Sandini, Enrico Tombetti, Elisa Calabrò, Luca Bernardo, Antonio Brucato Internal and Emergency Medicine, 2024
Ocular Manifestations in Juvenile Behçet’s Disease: A Registry-Based Analysis from the AIDA Network Carla Gaggiano, Abdurrahman Tufan, Silvana Guerriero, Gaafar Ragab, Jurgen Sota, Stefano Gentileschi, Stefania Costi, Ibrahim A. Almaghlouth, Andrea Hinojosa-Azaola, Samar Tharwat, Petros P. Sfikakis, Giuseppe Lopalco, Matteo Piga, Giovanni Conti, George Fragoulis, Angela Mauro, Ezgi D. Batu, Seza Ozen, Maria Tarsia, Francesco La Torre, Perla A. Kawakami-Campos, Antonio Vitale, Valeria Caggiano, Riza C. Kardaş, Gian Marco Tosi, Bruno Frediani, Tadej Avčin, José Hernández-Rodríguez, Luca Cantarini, Claudia Fabiani, and Ophthalmology and Therapy, 2024
Effectiveness and Safety of Biosimilars in Pediatric Non-infectious Uveitis: Real-Life Data from the International AIDA Network Uveitis Registry Maria Tarsia, Antonio Vitale, Carla Gaggiano, Jurgen Sota, Anna Maselli, Chiara Bellantonio, Silvana Guerriero, Rosanna Dammacco, Francesco La Torre, Gaafar Ragab, Mohamed Tharwat Hegazy, Alex Fonollosa, Maria Pia Paroli, Emanuela Del Giudice, Maria Cristina Maggio, Marco Cattalini, Lampros Fotis, Giovanni Conti, Angela Mauro, Adele Civino, Federico Diomeda, Alejandra de-la-Torre, Carlos Cifuentes-González, Samar Tharwat, José Hernández-Rodríguez, Verónica Gómez-Caverzaschi, Laura Pelegrín, Kalpana Babu, Vishali Gupta, Francesca Minoia, Piero Ruscitti, Stefania Costi, Luciana Breda, Saverio La Bella, Alessandro Conforti, Maria Antonietta Mazzei, Ester Carreño, Rana Hussein Amin, Salvatore Grosso, Bruno Frediani, Gian Marco Tosi, Alberto Balistreri, Luca Cantarini, Claudia Fabiani Ophthalmology and Therapy, 2024
Early anakinra treatment improves cardiac outcome of multisystem inflammatory syndrome in children, regardless of disease severity Andrea Taddio, Sara Della Paolera, Luisa Abbagnato, Anna Agrusti, Raffaele Badolato, Francesca Biscaro, Roberta Caorsi, Alessandro Consolaro, Rosa Maria Dellepiane, Marianna Fabi, Ilenia Floretta, Marco Gattorno, Manuela Giangreco, Francesco La Torre, Maria Cristina Maggio, Lorenzo Mambelli, Angela Mauro, Maria Vincenza Mastrolia, Alessandra Meneghel, Davide Montin, Francesca Ricci, Gabriele Simonini, Andrea Smarrazzo, Rita Sottile, Sara Stucchi, Maria Tardi, Lucio Verdoni, Gianvincenzo Zuccotti, Fiammetta Zunica, Angelo Ravelli, Marco Cattalini, P Adamoli, M C Alberelli, M Alessio, C Alizzi, P Barone, L A Baselli, V Bennato, F Biscaro, G Boscarol, G Bossi, A Campana, S Campus, M Carone, A Civino, G Conti, E Dei Rossi, E Del Giudice, A Dell'Anna, M De Luca, E Felici, G Filocamo, M L Foschini, R Gallizzi, S Giordano, S Lanciotti, B Lattanzi, A Lazzerotti, F Licciardi, A Manerba, S Mannarino, A Marino, A Marolda, L Martelli, G Martini, A Mazza, D Minasi, A Miniaci, F Minoia, A Olivieri, G Pennoni, R Pignataro, F Ricci, D Rigante, M Rossi, C Santagati, M Soliani, S Sonego, D Sperlì, B L Teruzzi, E Tierno, T Utytatnikova, P Valentini, G Vergine, and Rheumatology United Kingdom, 2024
Still’s disease continuum from childhood to elderly: data from the international AIDA Network Still’s disease registry Antonio Vitale, Valeria Caggiano, Giuseppe Lopalco, Henrique A Mayrink Giardini, Francesco Ciccia, Ibrahim A Almaghlouth, Piero Ruscitti, Petros P Sfikakis, Abdurrahman Tufan, Lorenzo Dagna, Roberto Giacomelli, Andrea Hinojosa-Azaola, Gafaar Ragab, Haner Direskeneli, Lampros Fotis, Jurgen Sota, Florenzo Iannone, Maria Morrone, Isabele Parente de Brito Antonelli, Marilia Ambiel Dagostin, Daniela Iacono, Martina Patrone, Kazi Asfina, Fehaid Alanazi, Ilenia Di Cola, Carla Gaggiano, Maria G Tektonidou, Riza Can Kardas, Hamit Kucuk, Corrado Campochiaro, Alessandro Tomelleri, Luca Navarini, Onorina Berardicurti, Eduardo Martín-Nares, Jiram Torres-Ruiz, Ayman Abdel-Monem Ahmed Mahmoud, Fatma Alibaz-Oner, Katerina Kourtesi, Maria Tarsia, Paolo Sfriso, Joanna Makowska, Marcello Govoni, Francesco La Torre, Maria Cristina Maggio, Sara Monti, Emanuela Del Giudice, Giacomo Emmi, Elena Bartoloni, José Hernández-Rodríguez, Verónica Gómez-Caverzaschi, Armin Maier, Gabriele Simonini, Annamaria Iagnocco, Giovanni Conti, Alma Nunzia Olivieri, Amato De Paulis, Alberto Lo Gullo, Ombretta Viapiana, Ewa Wiesik-Szewczyk, Sukran Erten, Benson Ogunjimi, Francesco Carubbi, Samar Tharwat, Katerina Laskari, Stefania Costi, Paola Triggianese, Anastasios Karamanakos, Alessandro Conforti, Micol Frassi, Gian Domenico Sebastiani, Antonio Gidaro, Angela Mauro, Alberto Balistreri, Claudia Fabiani, Bruno Frediani, Luca Cantarini Rmd Open, 2023
Outcomes of MIS-C patients treated with anakinra: a retrospective multicenter national study Francesco Licciardi, Carlotta Covizzi, Marta Dellepiane, Nicole Olivini, Maria Vincenza Mastrolia, Andrea Lo Vecchio, Viviana Monno, Maria Tardi, Angela Mauro, Maria Alessio, Giovanni Filocamo, Marco Cattalini, Andrea Taddio, Roberta Caorsi, Gian Luigi Marseglia, Francesco La Torre, Andrea Campana, Gabriele Simonini, Angelo Ravelli, Davide Montin Frontiers in Pediatrics, 2023
Efficacy and Safety of Adalimumab in Pediatric Non-infectious Non-anterior Uveitis: Real-life Experience From the International AIDA Network Uveitis Registry Antonio Vitale, Francesca Della Casa, Silvana Guerriero, Gaafar Ragab, Angela Mauro, Valeria Caggiano, Marco Cattalini, Emanuela Del Giudice, Rossella Favale, Carla Gaggiano, Irene Bellicini, Maria Pia Paroli, Mohamed Tharwat Hegazy, Jurgen Sota, Abdurrahman Tufan, Alberto Balistreri, Ibrahim Almaghlouth, Francesco La Torre, Ewa Więsik-Szewczyk, Maria Tarsia, Andrea Hinojosa-Azaola, Eduardo Martín-Nares, Bruno Frediani, Gian Marco Tosi, Alex Fonollosa, José Hernández-Rodríguez, Rana Hussein Amin, Giuseppe Lopalco, Donato Rigante, Luca Cantarini, Claudia Fabiani Ophthalmology and Therapy, 2023
Immunoglobulin, glucocorticoid, or combination therapy for multisystem inflammatory syndrome in children: a propensity-weighted cohort study Samuel Channon-Wells, Ortensia Vito, Andrew J McArdle, Eleanor G Seaby, Harsita Patel, Priyen Shah, Ekaterina Pazukhina, Clare Wilson, Claire Broderick, Giselle D'Souza, Ilana Keren, Ruud G Nijman, Adriana Tremoulet, Daniel Munblit, Rolando Ulloa-Gutierrez, Michael J Carter, Padmanabhan Ramnarayan, Tisham De, Clive Hoggart, Elizabeth Whittaker, Jethro A Herberg, Myrsini Kaforou, Aubrey J Cunnington, Oleg Blyuss, Michael Levin, Mohamed Chouli, Nacera Hamadouche, Mohamed Samir Ladj, Jorge Agrimbau Vázquez, Rodrigo Carmona, Adrian Gustavo Collia, Alejandro Ellis, Diego Natta, Laura Pérez, Mayra Rubiños, Natalia Veliz, Silvana Yori, Philip N. Britton, David P. Burgner, Emma Carey, Nigel W. Crawford, Hayley Giuliano, Alissa McMinn, Shirley Wong, Nicholas Wood, Wolfgang Holter, Matthias Krainz, Raphael Ulreich, Christoph Zurl, Joke Dehoorne, Filomeen Haerynck, Levi Hoste, Petra Schelstraete, Kristof Vandekerckhove, Jef Willems, Camila Giuliana Almeida Farias, Flávia Jacqueline Almeida, Izabel Alves Leal, André Ricardo Araujo da Silva, Anna Esther Araujo e Silva, Sabrina T.A. Barreiro, Daniella Gregória Bomfim Prado da Silva, Maria Celia Cervi, Mirian Viviane dos Santos Naja Cardoso, Cristiane Henriques Teixeira, Daniel Jarovsky, Julienne Martins Araujo, Eitan Naaman Berezin, Marco Aurélio Palazzi Sáfadi, Rolando Andres Paternina-de la Ossa, Cristina Souza Vieira, Anna Dimitrova, Margarita Ganeva, Stefan Stefanov, Albena Telcharova-Mihaylovska, Catherine M. Biggs, Alison Lopez, Rosie Scuccimarri, Ryan Tan, Sam Wasserman, Davinia Withington, Camila Ampuero, Javiera Aravena, Raul Bustos B, Daniel Casanova, Pablo Cruces, Franco Diaz, Tamara García-Salum, Loreto Godoy, Rafael A. Medina, Gonzalo Valenzuela Galaz, Germán Camacho-Moreno, María L. Avila-Aguero, Helena Brenes-Chacón, Kattia Camacho-Badilla, Gabriela Ivankovich-Escoto, Gabriela Naranjo-Zuniga, Alejandra Soriano-Fallas, Rolando Ulloa-Gutierrez, Adriana Yock-Corrales, Maysa Abbas Amer, Yasmine Abdelmeguid, Yomna H.H.Z. Ahmed, Adham Badib, Karim Badreldin, Yara Elkhashab, Hassan Heshmat, Amna Hussein, Amna Hussein Mohamed Hussein, Sandra Ibrahim, Walaa Shoman, Radwa M Yakout, Santtu Heinonen, François Angoulvant, Alexandre Belot, Naïm Ouldali, Florian Beske, Axel Heep, Katja Masjosthusmann, Karl Reiter, Ingeborg van den Heuvel, Ulrich von Both, Aikaterini Agrafiotou, Charalampos Antachopoulos, Konstantina Charisi, Irini Eleftheriou, Evangelia Farmaki, Lampros Fotis, Dimitrios Kafetzis, Patra Koletsi, Katerina Kourtesi, Stavroula Lampidi, Theodota Liakopoulou, Despoina Maritsi, Elisa Michailidou, Maria Milioudi, Ioanna Mparmpounaki, Eleni Papadimitriou, Vassiliki Papaevangelou, Emmanuel Roilides, Olga Tsiatsiou, Georgios Tsolas, Maria Tsolia, Petrina Vantsi, Linda Yajeira Banegas Pineda, Karla Leversia Borjas Aguilar, Edwin Mauricio Cantillano Quintero, Patrick Ip, Mike Yat Wah Kwan, Janette Kwok, Yu Lung Lau, Kelvin To, Joshua Sung Chih Wong, Mate David, David Farkas, Szofia Kalcakosz, Klaudia Szekeres, Borbala Zsigmond, Nadeem Aslam, Anthony Luder, Laura Andreozzi, Francesco Bianco, Valentina Bucciarelli, Danilo Buonsenso, Rolando Cimaz, Maia De Luca, Rosa Maria Dellepiane, Marianna Fabi, Emanuele Filice, Marcello Lanari, Andrea Lo Vecchio, Maria Vincenza Mastrolia, Angela Mauro, Angelo Mazza, Mario Virgilio Papa, Lorenza Romani, Sara Maria Scarano, Gabriele Simonini, Vincenzo Tipo, Lucio Verdoni, Anne-Marie Macharia, Grace Musiime, Bhupi Reel, Frederick Wangai, David Pace, Paul Torpiano, Nancy Anaya-Enriquez, Juan Manuel Carreon-Guerrero, Enrique Chacon-Cruz, Mariana Cheung López, Enrique Faugier Fuentes, Marisol Fonseca Flores, Miguel García-Domínguez, Ana Luisa Giron Vargas, Ivan Lopez-Delgado, Liliana Lopez Hernández, Hector F. Menchaca Aguayo, Jesus Gilberto Montaño-Duron, Giordano Pérez-Gaxiola, Pamela Ramos Tiñini, Edgardo Tostado-Morales, Julio Valadez, Christopher Inchley, Sjur Klevberg, Per Kristian Knudsen, Per Helge Måseide, Jose Manuel Carrera, Elizabeth Castaño, Carlos Alberto Daza Timana, Tirza De Leon, Dora Estripeaut, Jacqueline Levy, Ximena Norero, Javier Record, Magda Rojas-Bonilla, Mayra Wong, Ricardo Iramain, Roger Hernandez, Gian Huamán, Manuel Munaico, Carlos Peralta, Diego Seminario, Elmer Hans Zapata Yarlequé, Justyna Gadzinska, Kamila Ludwikowska, Joanna Mandziuk, Magdalena Okarska-Napierała, Zalina A. Alacheva, Ekaterina Alexeeva, Petr V. Ananin, Margarita Antsupova, Maya D. Bakradze, Anna Berbenyuk, Polina Bobkova, Svetlana Borzakova, Irina L. Chashchina, Yasmin El-Taravi, Andrey P. Fisenko, Marina S. Gautier, Anastasia Glazyrina, Cyrill Gorlenko, Mariia Grosheva, Herman Kiselev, Elena Kondrikova, Evgeniya Korobyants, Anatoliy A. Korsunskiy, Karina Kovygina, Ekaterina Krasnaya, Seda Kurbanova, Maria K. Kurdup, Anna V. Mamutova, Lyudmila Mazankova, Ilya L. Mitushin, Daniel Munblit, Anzhelika Nargizyan, Yanina O. Orlova, Ismail M. Osmanov, Anastasia S. Polyakova, Anna Pushkareva, Olga Romanova, Elmira Samitova, Anastasia Shvedova, Anna Sologub, Ekaterina Iakovleva, Rustem F. Tepaev, Anna A. Tkacheva, Margarita Yegiyan, Valeriya Yusupova, Elena Zholobova, Carlos Daniel Grasa, Cristina Epalza, Nuria Lopez Segura, Federico Martinon-Torres, Susana Melendo, Ana Mendez-Echevarria, Juan Miguel Mesa Guzmán, Jorge Roberto Palacios Argueta, Irene Rivero-Calle, Jacques Rivière, Moisés Rodríguez-González, Pablo Rojo, Judith Sanchez Manubens, Pere Soler-Palacin, Antoni Soriano-Arandes, Alfredo Tagarro, Serena Villaverde, Maria Altman, Petter Brodin, AnnaCarin Horne, Karin Palmblad, Barbara Brotschi, Patrick Meyer Sauteur, Jana Pachlopnik Schmid, Seraina Prader, Christa Relly, Luregn J. Schlapbach, Michelle Seiler, Sophie Strasser, Johannes Trück, Kathrin Weber, Daniela Wütz, Alaa Hamdan, Ibrahim Melhem, Ahmed Moussa, Joke Dunk, Naomi Ketharanathan, Clementien Vermont, Esra Akyüz Özkan, Benhur Sirvan Cetin, Emine Hafize Erdeniz, Irfan Oğuz Şahin, Galina Borisova, Oksana Boyarchuk, Lidiya Boychenko, Yaryna Boyko, Nadiia Diudenko, Olha Dyvonyak, Olexandr Kasiyan, Kostiantyn Katerynych, Larysa Kostyuchenko, Marina Mamenko, Kateryna Melnyk, Nelia Miagka, Liliya Nazarenko, Iryna Nezgoda, Stanislava Rykova, Olga Svyst, Maria Teslenko, Mykola Trykosh, Nataliya Vasilenko, Alla Volokha, Charlotte Adams, Toju Akomolafe, Eslam Al-Abadi, Nele Alders, Styliani Alifieraki, Hareef Ansumanu, Emily Aston, Paula Avram, Alasdair Bamford, Millie Banks, Robin Basu Roy, Thomas Beattie, Olga Boleti, Abbey Bracken, Jonathan Broad, James Cai, Enitan D. Carrol, Michael Carter, Anchit Chandran, James Charlesworth, Jaya Chawla, Hannah Cooper, Samantha Cooray, Patrick Davies, Francesca Davis, Simon B. Drysdale, Ella Dzora, Marieke Emonts, Ceri Evans, Katy Fidler, Caroline Foster, Chen Gong, Berin Gongrun, Carmen Gonzalez, Berin Gorgun, Louis Grandjean, Karlie Grant, Jonathan Guo, Yael Hacohen, Jack Hall, Hytham K.S. Hamid, Jane Hassell, Christine Hesketh, Jessica Hewlett, Ahmad Hnieno, Hannah Holt-Davis, Aleena Hossain, Shiying Hu, Lee D. Hudson, Sharon Jheeta, Mae Johnson, Sarah Johnson, Deepthi Jyothish, Beate Kampmann, Akhila Kavirayani, Deborah Kelly, Arangan Kirubakaran, Filip Kucera, Daniel Langer, George Lawson, Emily A Lees, Rebecca Lenihan, Jon Lillie, Katherine Longbottom, Hermione Lyall, Niamh Mackdermott, Sarah Maltby, Thomas Mclelland, Anne-Marie McMahon, Danielle Miller, Mariana Miranda, Luwaiza Mirza, Zoe Morrison, Karyn Moshal, Jennifer Muller, Phoebe Musuka, Evangelia Myttaraki, Simon Nadel, Sreedevi Nair, Luke Nuttall, Oyinkansola Oremakinde, Daniella Osaghae, Fatima Osman, Anna Ostrzewska, Davide Paccagnella, Mrinalini Panthula, Eleni Papachatzi, Charalampia Papadopoulou, Fahim Patel, Harsita Patel, Helen Payne, Justin Penner, Shervin Polandi, Andrew J. Prendergast, Padmanabhan Ramnarayan, Lasith Ranasinghe, Muthukumaran Ravichandran, Sophie Rhys-Evans, Andrew Riordan, Charlene M.C. Rodrigues, Lauren Roe, Sam Romaine, Nina Schobi, James Seddon, Delane Shingadia, Oishi Sikdar, Anand Srivastava, Siske Struik, Thomas Sun, Rachel Wei Tan, Alice Taylor, Amanda Taylor, Andrew Taylor, Steven Tran, Stavros Tsagkaris, Gareth Tudor-Williams, Sarah van den Berg, Fabian van der Velden, Lyn Ventilacion, Paul A. Wellman, Joseph Withers Green, Michael P. Yanney, Shunmay Yeung, Aditya Badheka, Sarah Badran, Dwight M. Bailey, Anna Kathryn Burch, Jane C. Burns, Catherine Cichon, Blake Cirks, Michael D. Dallman, Dennis R. Delany, Mary Fairchok, Samantha Friedman, Jennifer Geracht, Allison Langs-Barlow, Kelly Mann, Amruta Padhye, Alexis Quade, Kacy Alyne Ramirez, John Rockett, Imran Ali Sayed, Roberto P. Santos, Amr A. Shahin, Adriana Tremoulet, Samuel Umaru, Rebecca Widener, Hilda Angela Mujuru, Gwendoline Kandawasvika Lancet Rheumatology, 2023
Acute appendicitis in infants Rossella Turco, Angela Mauro, Paolo Quitadamo, Giovanni Gaglione, Francesco Esposito, Giovanni Di Nardo, Vincenzo Tipo Journal of Pediatric Surgery Case Reports, 2023
Preliminary data revealing efficacy of Streptococcus salivarius K12 (SSK12) in Periodic Fever, Aphthous stomatitis, Pharyngitis, and cervical Adenitis (PFAPA) syndrome: A multicenter study from the AIDA Network PFAPA syndrome registry Francesco La Torre, Jurgen Sota, Antonella Insalaco, Giovanni Conti, Emanuela Del Giudice, Riccardo Lubrano, Luciana Breda, Maria Cristina Maggio, Adele Civino, Violetta Mastrorilli, Roberta Loconte, Marco Francesco Natale, Camilla Celani, Mery Romeo, Serena Patroniti, Cristina Gentile, Antonio Vitale, Valeria Caggiano, Carla Gaggiano, Federico Diomeda, Marco Cattalini, Giuseppe Lopalco, Giacomo Emmi, Paola Parronchi, Stefano Gentileschi, Fabio Cardinale, Emma Aragona, Farhad Shahram, Achille Marino, Patrizia Barone, Carla Moscheo, Burcugul Ozkiziltas, Francesco Carubbi, Ohoud Alahmed, Ludovica Iezzi, Benson Ogunjimi, Angela Mauro, Maria Tarsia, Ayman Abdel-Monem Ahmed Mahmoud, Henrique Ayres Mayrink Giardini, Petros P. Sfikakis, Katerina Laskari, Ewa Więsik-Szewczyk, José Hernández-Rodríguez, Bruno Frediani, Verónica Gómez-Caverzaschi, Abdurrahman Tufan, Ibrahim A. Almaghlouth, Alberto Balistreri, Gaafar Ragab, Claudia Fabiani, Luca Cantarini, Donato Rigante Frontiers in Medicine, 2023
A patient-driven registry on Behçet’s disease: the AIDA for patients pilot project Carla Gaggiano, Alessandra Del Bianco, Jurgen Sota, Stefano Gentileschi, Piero Ruscitti, Roberto Giacomelli, Matteo Piga, Francesca Crisafulli, Sara Monti, Giacomo Emmi, Amato De Paulis, Antonio Vitale, Maria Tarsia, Valeria Caggiano, Rossana Nuzzolese, Veronica Parretti, Claudia Fabiani, Giuseppe Lopalco, Armin Maier, Marco Cattalini, Donato Rigante, Marcello Govoni, Francesca Li Gobbi, Serena Guiducci, Paola Parronchi, Achille Marino, Francesco Ciccia, Maria Cristina Maggio, Emma Aragona, Elena Bartoloni, Annamaria Iagnocco, Ombretta Viapiana, Gian Domenico Sebastiani, Silvana Guerriero, Antonella Insalaco, Emanuela Del Giudice, Giovanni Conti, Patrizia Barone, Alma Nunzia Olivieri, Antonio Brucato, Francesco Carubbi, Paola Triggianese, Angela Mauro, Gian Marco Tosi, Alex Fonollosa, Henrique Ayres Mayrink Giardini, Gaafar Ragab, Samar Tharwat, José Hernández-Rodríguez, Petros P. Sfikakis, Katerina Laskari, Anastasios Karamanakos, Gerard Espinosa, Farhad Shahram, Haner Direskeneli, Andrea Hinojosa-Azaola, Daniela Opris-Belinski, Ibrahim A. AlMaghlouth, Gülen Hatemi, Mehmet Akif Eksin, Fatos Önen, Ewa Więsik-Szewczyk, Nurullah Akkoç, Abdurrahman Tufan, Ali Şahin, Şükran Erten, Seza Ozen, Ezgi Deniz Batu, Bruno Frediani, Alberto Balistreri, Luca Cantarini Frontiers in Medicine, 2023
Is COVID-19 a hyperferritinemic syndrome in children? Antonietta Giannattasio, Carolina D’Anna, Stefania Muzzica, Angela Mauro, Margherita Rosa, Francesca Angrisani, Sabrina Acierno, Fabio Savoia, Vincenzo Tipo Clinical Chemistry and Laboratory Medicine, 2021
Skin manifestations and coeliac disease in paediatric population Flavia Persechino, Gloria Galli, Severino Persechino, Francesco Valitutti, Letizia Zenzeri, Angela Mauro, Vito Domenico Corleto, Pasquale Parisi, Chiara Ziparo, Melania Evangelisti, Giovanna Quatrale, Giovanni Di Nardo Nutrients, 2021
Treatment of Multisystem Inflammatory Syndrome in Children Andrew J. McArdle, Ortensia Vito, Harsita Patel, Eleanor G. Seaby, Priyen Shah, Clare Wilson, Claire Broderick, Ruud Nijman, Adriana H. Tremoulet, Daniel Munblit, Rolando Ulloa-Gutierrez, Michael J. Carter, Tisham De, Clive Hoggart, Elizabeth Whittaker, Jethro A. Herberg, Myrsini Kaforou, Aubrey J. Cunnington, Michael Levin New England Journal of Medicine, 2021
Dieulafoy lesion: Two pediatric case reports Giovanni Di Nardo, Gianluca Esposito, Angela Mauro, Letizia Zenzeri, Gian Paolo Ciccarelli, Andrea Catzola, Alessandro Rossi, Vito Domenico Corleto Italian Journal of Pediatrics, 2020
A national cohort study on pediatric Behçet's disease: Cross-sectional data from an Italian registry Romina Gallizzi, Caterina Pidone, Luca Cantarini, Martina Finetti, Marco Cattalini, Giovanni Filocamo, Antonella Insalaco, Donato Rigante, Rita Consolini, Maria Cristina Maggio, Adele Civino, Silvana Martino, Alma Nunzia Olivieri, Giovanna Fabio, Serena Pastore, Angela Mauro, Diana Sutera, Giuseppe Trimarchi, Nicolino Ruperto, Marco Gattorno, Rolando Cimaz Pediatric Rheumatology, 2017
Kawasaki disease: An epidemiological study in central Italy Angela Mauro, Marianna Fabi, Monica Da Frè, Paolo Guastaroba, Elena Corinaldesi, Giovanni Battista Calabri, Teresa Giani, Gabriele Simonini, Franca Rusconi, Rolando Cimaz Pediatric Rheumatology, 2016
Hyper-IgD syndrome (HIDS): Description of a clinical case Medico E Bambino, 2015
